Androgen receptor (AR) amplification in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) and enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WC

TitleAndrogen receptor (AR) amplification in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) resistant to abiraterone (Abi) and enzalutamide (Enz): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WC
Publication TypeMiscellaneous
Year of Publication2015
AuthorsAggarwal, RRaj, Thomas, G, Youngren, J, Foye, A, Olson, S, Paris, P, Beer, TM, Ryan, CJ, Witte, O, Evans, CP, ,